The WIRION® system is used to hold and remove debris or blood clots from the lower limbs that can be associated with atherectomyExternal Link Disclaimerprocedures. See more Customers in the U.S. with questions about this recall should contact Cardiovascular Systems Inc. by phone at 651-259-2800. See more Cardiovascular Systems Inc. is recalling the WIRION system due to complaints of filter breakage during retrieval. Under certain … See more On November 22, 2024, Cardiovascular Systems Inc. sent an urgent notification recall letter to customers instructing them: 1. Remove the device from distribution and return the device to Cardiovascular Systems Inc. See more WebAug 5, 2024 · The Wirion device is a distal embolic protection filter that is used to capture debris that can be associated with all types of peripheral vascular interventions. CSI plans to commercialize the Wirion system in the United States after the transfer of manufacturing from Gardia Medical, which is expected to be completed after a 12- to 15-month ...
Reimbursement Coding CSI360
WebMar 17, 2024 · Device offers a streamlined approach for lower extremity embolic protection Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company … WebNov 24, 2024 · The company plans to voluntarily recall all WIRION units currently in customer inventory. In total, 697 devices were distributed in the U.S. between March 22, 2024 and November 15, 2024. All lots ... raw html omitted
Cardiovascular Systems, Inc. Reports Fiscal 2024 Second ... - Benzinga
WebApr 10, 2024 · Protecting reimbursement and coverage. At CSI, our commitment to patients, physicians and hospitals doesn’t end with delivering unique technology. Our team collaborates with leading experts and encourages policy organizations to support patient access and appropriate reimbursement for high-quality interventional treatments for PAD … WebAug 6, 2024 · CSI plans to commercialize the WIRION System in the United States following the transfer of manufacturing from Gardia Medical. CSI expects the manufacturing transfer to be completed after a 12- to 15-month transition period. Gardia will retain the rights to the WIRION System for angioplasty and stenting procedures in the carotid arteries. WebNov 25, 2024 · Cardiovascular Systems has initiated a voluntary recall of unused Wirion embolic protection systems due to complaints of filter breakage during retrieval. Wirion is a distal embolic protection filter used … simpleflips bup